Singh, Ranjan Kumar, M.D.: Clinical Trials

3 trials sponsored by Singh, Ranjan Kumar, M.D., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. .

Follow Singh, Ranjan Kumar, M.D.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevalence of Substance Abuse Among Anti-retroviral Treatment Naive Patients Positive for HIV Antibodies
Substance like alcohol, marijuana, etc. - HIV Infections
CompletedSingh, Ranjan Kumar, M.D.2102021-04-012022-03-17
Prevalence of HIV +ve Cases With AIDS Defining Opportunistic Infections Among ART Naive Patients Attending ART Centre
CD4 cell count - HIV Infections, Tuberculosis
CompletedSingh, Ranjan Kumar, M.D.2572019-06-012020-03-19
HIV-Tb Confections Among HIV Patients
HIV
CompletedSingh, Ranjan Kumar, M.D.2192015-06-012017-10-04

Conditions studied

HIV Infections (2)  ·  Candidiasis (1)  ·  Cryptococcosis (1)  ·  Leishmaniasis (1)  ·  Opportunistic Infections (1)  ·  Substance-Related Disorders (1)  ·  Toxoplasmosis (1)  ·  Tuberculosis (1)

Interventions

CD4 Lymphocyte Count (1)  ·  Ethanol (1)  ·  nabiximols (1)

Countries

India (3)

Top investigators

Ranjan K Singh, M.D. (2)  ·  Ranjan K Singh (1)